Urine microRNAs as potential noninvasive biomarkers in urologic cancers
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/01/01
-
Indian UGC (journal)
-
Refrences41
-
Citations61
-
Hana Mlcochova
-
Renata Hezova
-
Michal Stanik
-
Ondrej Slaby
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
You May Also Like
- Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer
- Could inflammation be a key component in the progression of benign prostatic hyperplasia?
- Renal cell carcinoma: etiology, incidence and epidemiology
- Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
- Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| MicroRNA 15a, Inversely Correlated to PKCα, Is a Potential Marker to Differentiate between Benign and Malignant Renal Tumors in Biopsy and Urine Samples | The American Journal of Pathology |
| 82 | 2012 |
MiR‐34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53‐Rb pathway status | International Journal of Cancer |
| 72 | 2012 |
| Changes in circulating microRNA levels associated with prostate cancer | British Journal of Cancer |
| 499 | 2012 |
Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients | Genes, Chromosomes and Cancer |
| 84 | 2012 |
| Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer | International Journal of Oncology |
| 96 | 2012 |
Refrences Analysis
The category
Medicine: Medicine (General) 29
is the most frequently represented among the references in this article. It primarily includes studies from Clinical Chemistry and The American Journal of Pathology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| A review of cancer data fusion methods based on deep learning | Information Fusion |
| 2024 | |
| The Effect of Blood Clots on the Quality of RNA Extracted from PAXgene Blood RNA Tubes | Biopreservation and Biobanking |
| 1 | 2024 |
| Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard? | Expert Review of Anticancer Therapy |
| 1 | 2023 |
Canine urothelial carcinoma: a pilot study of microRNA detection in formalin-fixed, paraffin-embedded tissue samples and in normal urine | Journal of Veterinary Diagnostic Investigation |
| 2023 | |
Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis | Technology in Cancer Research & Treatment |
| 5 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 33
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer and was published in 2014. The most recent citation comes from a 2024 study titled A review of cancer data fusion methods based on deep learning. This article reached its peak citation in 2015, with 14 citations. It has been cited in 50 different journals, 30% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.